25 days ago
A portion of a major California highway has been renamed after Hollywood icon James Dean 71 years after he died in a fiery crash on the road while driving to a race in Salinas.
Caltrans officials were joined by representatives of the late star in the town of Cholame on Wednesday where a segment of Highway 46—which connects the coast with the Central Valley—officially became the James Dean Memorial Highway.
"Yesterday's ceremony marked 71 years since Dean's tragic crash, and local leaders, CHP, and community advocates came together with one message: safer roads save lives," the announcement read, referring to the designation near the site of Dean's fatal 1955 crash.
James Dean is shown in a scene from the film "East of Eden" in 1955. Courtesy Everett Collection
A 1950 Ford Tudor driven by Donald Turnupseed and James Dean's Porsche collided in a crash on Highway 41 in 1955. newsnationnow.com
#james
Caltrans officials were joined by representatives of the late star in the town of Cholame on Wednesday where a segment of Highway 46—which connects the coast with the Central Valley—officially became the James Dean Memorial Highway.
"Yesterday's ceremony marked 71 years since Dean's tragic crash, and local leaders, CHP, and community advocates came together with one message: safer roads save lives," the announcement read, referring to the designation near the site of Dean's fatal 1955 crash.
James Dean is shown in a scene from the film "East of Eden" in 1955. Courtesy Everett Collection
A 1950 Ford Tudor driven by Donald Turnupseed and James Dean's Porsche collided in a crash on Highway 41 in 1955. newsnationnow.com
#james
29 days ago
The Council on American-Islamic Relations (CAIR), antifa and the Muslim Brotherhood will be labeled domestic terrorist organizations under a new state law, after Florida leaders OK'd the designations at their Sept. 29 meeting.
These designations were in a 427-page packet submitted by the Florida Department of Law Enforcement for approval by Gov. Ron DeSantis and Florida Cabinet members: Attorney General James Uthmeier, Agriculture Commissioner Wilton Simpson and state Chief Financial Officer Blaise Ingoglia.
The packet also named numerous other groups labeled by the federal government as foreign terrorist organizations.
Although the Governor and Florida Cabinet approved these notices without any discussion, these designations don't come as a surprise. Weeks earlier, the governor and Cabinet approved an emergency rule setting procedures under a new state law (HB 1471) allowing them to designate terror groups.
Additionally, the day this law took effect, DeSantis announced his intentions to declare CAIR, the country's largest Muslim advocacy group, and antifa as domestic terror groups.
#Florida #muslim #governor
These designations were in a 427-page packet submitted by the Florida Department of Law Enforcement for approval by Gov. Ron DeSantis and Florida Cabinet members: Attorney General James Uthmeier, Agriculture Commissioner Wilton Simpson and state Chief Financial Officer Blaise Ingoglia.
The packet also named numerous other groups labeled by the federal government as foreign terrorist organizations.
Although the Governor and Florida Cabinet approved these notices without any discussion, these designations don't come as a surprise. Weeks earlier, the governor and Cabinet approved an emergency rule setting procedures under a new state law (HB 1471) allowing them to designate terror groups.
Additionally, the day this law took effect, DeSantis announced his intentions to declare CAIR, the country's largest Muslim advocacy group, and antifa as domestic terror groups.
#Florida #muslim #governor
1 month ago
The Ethereum (CRYPTO: ETH) cryptocurrency is up 5.8% at 2:17 p.m. ET, floating atop a broad surge across the crypto sector. It's the kind of day where you almost expect stablecoins to rise, as the U.S. Securities and Exchange Commission (SEC) moved one step closer to permitting token-based trading of stock-type securities.
And Ethereum would benefit directly if tokenized stocks ever get the SEC's final stamp of approval. The news is a day old, but traders needed time to process the situation after a tumultuous week in which the Clarity Act failed to move forward.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
The SEC is allowing a new kind of venue to trade blockchain versions of regularly listed stocks without first registering as a stock exchange. It's temporary, it's capped, and it comes with strings attached.
This isn't retail investors buying tokenized stocks on a public blockchain tomorrow. It's explicitly a placeholder for further announcements. The tokenized securities venue (TSV) designation is essentially a bold but limited experiment.
#stocks #missed #investors
And Ethereum would benefit directly if tokenized stocks ever get the SEC's final stamp of approval. The news is a day old, but traders needed time to process the situation after a tumultuous week in which the Clarity Act failed to move forward.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
The SEC is allowing a new kind of venue to trade blockchain versions of regularly listed stocks without first registering as a stock exchange. It's temporary, it's capped, and it comes with strings attached.
This isn't retail investors buying tokenized stocks on a public blockchain tomorrow. It's explicitly a placeholder for further announcements. The tokenized securities venue (TSV) designation is essentially a bold but limited experiment.
#stocks #missed #investors
1 month ago
On September 15, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) completed its acquisition of privately held Actio Biosciences for $820 million upfront, adding a clinical-stage epilepsy drug called ABS-1230 to its rare disease pipeline. The deal lands weeks after Jazz posted its highest quarterly revenue ever on August 3, and raised its full-year guidance, so a fresh acquisition now sits on top of a business that was already accelerating. The question for investors is whether that combination adds up to durable growth or just a bigger bill.
ABS-1230 targets KCNT1-related epilepsy, a rare and hard-to-treat form of the disease. In an early clinical proof-of-concept trial, children who received the drug experienced meaningful seizure reductions, and preclinical testing showed it inhibited KCNT1 across every pathogenic mutation researchers evaluated, hinting it could work across the whole patient population rather than a narrow subset. The FDA has already granted ABS-1230 Orphan Drug, Rare Pediatric Disease and Fast Track designations, and accepted it into the agency's Rare Disease Evidence Principles process, a set of regulatory advantages that can speed a drug toward approval.
The acquisition also arrives while Jazz's existing business is firing on multiple cylinders. Second-quarter revenue climbed 16% year over year to $1.2 billion, the company's highest quarterly total on record, and management raised full-year 2026 revenue guidance to a range of $4.6 billion to $4.75 billion. Growth was not confined to one product. Xywav sales rose 13% to $471 million on 525 net new patients, Epidiolex grew 16% to $292 million, and Zepzelca jumped 42% to $106 million. Zanidatamab, sold as Ziihera in biliary tract cancer, also received Breakthrough Therapy designation from the FDA for a form of colorectal cancer, adding another avenue for the oncology franchise Jazz has been building beyond its epilepsy and sleep businesses.
None of that came free. The $820 million upfront payment for Actio lands on top of $4.4 billion in long-term debt that Jazz already carried as of June 30, even after the company used part of its cash to repay $1.0 billion of exchangeable notes that matured this year. Cash, equivalents and investments stood at $2.2 billion at that point, meaning the Actio payment alone accounts for a meaningful share of the company's liquid resources.
Jazz's recent history also shows how acquisitions can distort the bottom line before they pay off. A $905.4 million in-process research and development charge tied to the 2025 Chimerix acquisition pushed second-quarter 2025 GAAP earnings to a loss of $11.74 per share, and a smaller $77 million IPR&D charge from the AbCellera and Werewolf deals still dented second-quarter 2026 results. ABS-1230 itself remains early, with only proof-of-concept data in hand and no late-stage trial results yet. The portfolio is not without setbacks, either. Jazz is moving to voluntarily drop the second-line indication for Zepzelca in meta
ABS-1230 targets KCNT1-related epilepsy, a rare and hard-to-treat form of the disease. In an early clinical proof-of-concept trial, children who received the drug experienced meaningful seizure reductions, and preclinical testing showed it inhibited KCNT1 across every pathogenic mutation researchers evaluated, hinting it could work across the whole patient population rather than a narrow subset. The FDA has already granted ABS-1230 Orphan Drug, Rare Pediatric Disease and Fast Track designations, and accepted it into the agency's Rare Disease Evidence Principles process, a set of regulatory advantages that can speed a drug toward approval.
The acquisition also arrives while Jazz's existing business is firing on multiple cylinders. Second-quarter revenue climbed 16% year over year to $1.2 billion, the company's highest quarterly total on record, and management raised full-year 2026 revenue guidance to a range of $4.6 billion to $4.75 billion. Growth was not confined to one product. Xywav sales rose 13% to $471 million on 525 net new patients, Epidiolex grew 16% to $292 million, and Zepzelca jumped 42% to $106 million. Zanidatamab, sold as Ziihera in biliary tract cancer, also received Breakthrough Therapy designation from the FDA for a form of colorectal cancer, adding another avenue for the oncology franchise Jazz has been building beyond its epilepsy and sleep businesses.
None of that came free. The $820 million upfront payment for Actio lands on top of $4.4 billion in long-term debt that Jazz already carried as of June 30, even after the company used part of its cash to repay $1.0 billion of exchangeable notes that matured this year. Cash, equivalents and investments stood at $2.2 billion at that point, meaning the Actio payment alone accounts for a meaningful share of the company's liquid resources.
Jazz's recent history also shows how acquisitions can distort the bottom line before they pay off. A $905.4 million in-process research and development charge tied to the 2025 Chimerix acquisition pushed second-quarter 2025 GAAP earnings to a loss of $11.74 per share, and a smaller $77 million IPR&D charge from the AbCellera and Werewolf deals still dented second-quarter 2026 results. ABS-1230 itself remains early, with only proof-of-concept data in hand and no late-stage trial results yet. The portfolio is not without setbacks, either. Jazz is moving to voluntarily drop the second-line indication for Zepzelca in meta
1 month ago
On September 14, American Battery Technology Company (NASDAQ:ABAT) held its fiscal year 2026 earnings call, and for once the numbers matched the ambition. Revenue at its flagship recycling facility jumped more than 400% to $21.7 million, and the company posted its first-ever adjusted gross profit. But on the same call, CEO Ryan Melsert disclosed a federal directive that could choke off exports of one of the plant's key products, black mass, a reminder that ABAT's fortunes are still tied tightly to Washington.
Revenue jumped over 400% year over year to $21.7 million, fueled by higher throughput at the company's first recycling facility and increased sales of byproducts. Cost of goods sold rose only 67% over the same stretch, evidence that fixed costs are spreading across a much bigger volume of material. Even more telling, operating cash spend actually fell 16% even as throughput at the plant more than quadrupled. That combination pushed American Battery Technology to an adjusted gross profit of $1.7 million, a sharp turnaround from the $6.2 million loss it posted a year earlier.
The balance sheet tells a similar story. Cash climbed to $49.5 million as of June 30, 2026, and total ***** ets reached $133 million, up sharply from the prior year. The company also erased all of its long-term debt during the year, leaving it with a clean balance sheet heading into a period of heavy capital spending.
Growth plans are already in motion. A second recycling facility planned for the Southeast U.S., designed to process 100,000 tons of batteries a year, is backed by a $150 million grant from the Department of Energy, and a separate $10 million DOE grant is funding three next-generation recycling technologies. On the mining side, the Bureau of Land Management certified the company's plan of operations for its Tonopah lithium project in Nevada, home to an identified 21.3 million tons of lithium hydroxide, including 2.7 million tons of proven and probable reserves. The project also won a FAST-41 priority designation, intended to speed up federal permitting.
The clearest risk surfaced on the call itself. The US Department of Commerce issued a directive that effectively bans the export of black mass, the concentrated metal byproduct of battery recycling, unless a company obtains a specific exception. American Battery Technology has submitted a request for that exception, but as of the call, Commerce had not issued a formal response, and the company is storing black mass at its facility in the meantime.
#company #recycling #black
Revenue jumped over 400% year over year to $21.7 million, fueled by higher throughput at the company's first recycling facility and increased sales of byproducts. Cost of goods sold rose only 67% over the same stretch, evidence that fixed costs are spreading across a much bigger volume of material. Even more telling, operating cash spend actually fell 16% even as throughput at the plant more than quadrupled. That combination pushed American Battery Technology to an adjusted gross profit of $1.7 million, a sharp turnaround from the $6.2 million loss it posted a year earlier.
The balance sheet tells a similar story. Cash climbed to $49.5 million as of June 30, 2026, and total ***** ets reached $133 million, up sharply from the prior year. The company also erased all of its long-term debt during the year, leaving it with a clean balance sheet heading into a period of heavy capital spending.
Growth plans are already in motion. A second recycling facility planned for the Southeast U.S., designed to process 100,000 tons of batteries a year, is backed by a $150 million grant from the Department of Energy, and a separate $10 million DOE grant is funding three next-generation recycling technologies. On the mining side, the Bureau of Land Management certified the company's plan of operations for its Tonopah lithium project in Nevada, home to an identified 21.3 million tons of lithium hydroxide, including 2.7 million tons of proven and probable reserves. The project also won a FAST-41 priority designation, intended to speed up federal permitting.
The clearest risk surfaced on the call itself. The US Department of Commerce issued a directive that effectively bans the export of black mass, the concentrated metal byproduct of battery recycling, unless a company obtains a specific exception. American Battery Technology has submitted a request for that exception, but as of the call, Commerce had not issued a formal response, and the company is storing black mass at its facility in the meantime.
#company #recycling #black
2 months ago
Veteran defensive back L'Jarius Sneed was listed on the Kansas City Chiefs' final injury report ahead of the team's Week 1 matchup against the Denver Broncos on 'Monday Night Football.'
Should fans expect to see Sneed take the field in Kansas City's home opener at Arrowhead Stadium on September 14?
Here's the latest update on Sneed's status in Week 1:
Sneed was downgraded to limited participation in practice on Saturday due to a knee injury, but the Chiefs declined to give him an official game status designation for Kansas City's rivalry tilt with Denver.
Here's the final injury report for the Chiefs and Broncos. pic.twitter.com/rDKVjH6WH0
#sneed #chiefs #final #status
Should fans expect to see Sneed take the field in Kansas City's home opener at Arrowhead Stadium on September 14?
Here's the latest update on Sneed's status in Week 1:
Sneed was downgraded to limited participation in practice on Saturday due to a knee injury, but the Chiefs declined to give him an official game status designation for Kansas City's rivalry tilt with Denver.
Here's the final injury report for the Chiefs and Broncos. pic.twitter.com/rDKVjH6WH0
#sneed #chiefs #final #status
2 months ago
As Detroit's 2026 regular-season opener on Sunday, Sept. 13 against New Orleans nears, the Lions listed just one player with an injury designation on their Friday injury report.
Defensive back Christian Izien was listed as questionable after being a limited participant for the third straight day with his groin injury.
"He's doing well. We felt really good about him. He's close. I want to see what he looks like running around today and then knowing that we're going on a short week after this, that'll have a bearing on it, too. But, he's moving around really well. I feel like he's a little ahead of schedule in a good way. We'll see," Campbell said of Izien's injury status on Friday morning.
Izien, 26, signed a one-year, $2 million deal with the Lions in March.
Unfortunately for Izien, three consecutive limited practices puts him behind the eight-ball in terms of being elevated to active on Sunday. The Lions' Week 2 matchup against the Buffalo Bills is Thursday, Sept. 17. With that short turnaround, if Izien misses the opener, he could miss each of the Lions' first two games of 2026.
#sept
Defensive back Christian Izien was listed as questionable after being a limited participant for the third straight day with his groin injury.
"He's doing well. We felt really good about him. He's close. I want to see what he looks like running around today and then knowing that we're going on a short week after this, that'll have a bearing on it, too. But, he's moving around really well. I feel like he's a little ahead of schedule in a good way. We'll see," Campbell said of Izien's injury status on Friday morning.
Izien, 26, signed a one-year, $2 million deal with the Lions in March.
Unfortunately for Izien, three consecutive limited practices puts him behind the eight-ball in terms of being elevated to active on Sunday. The Lions' Week 2 matchup against the Buffalo Bills is Thursday, Sept. 17. With that short turnaround, if Izien misses the opener, he could miss each of the Lions' first two games of 2026.
#sept
2 months ago
WASHINGTON, Sept 9 (Reuters) - Three U.S. lawmakers have called on the American government to blacklist a set of Indian IT firms over what they describe as "more than fifteen years of targeted espionage against U.S. citizens, businesses, and the lawyers representing them."
In a letter issued Wednesday, Democratic Senators Ron Wyden and Sheldon Whitehouse, along with Republican Representative Pat Harrigan, asked the Commerce Department to add BellTroX, CyberRoot, and Sunkissed Organic Farms Pvt. Ltd. (formerly known as "Appin Technology Pvt. Ltd.") and its subsidiaries, to the Commerce Department's Entity List. Such a designation would cut them off from U.S. software, cloud infrastructure, and cybersecurity tools.
Sunkissed representatives, CyberRoot and the Commerce Department did not respond to requests for comment. BellTroX could not be reached for comment.
All three companies have been described in media coverage and in reports published by major tech firms as being fronts for hack-for-hire activities.
In 2022, Reuters named CyberRoot and BellTroX as key players in the cybermercenary industry, saying they were frequently tapped by Western lawyers and private investigators to spy on one another during legal and business disputes. A 2023 Reuters report identified Appin as a pioneer in the field, saying the company grew from an educational startup to a hack-for-hire powerhouse that stole secrets from executives, politicians, military officials and wealthy elites around the globe.
#three
In a letter issued Wednesday, Democratic Senators Ron Wyden and Sheldon Whitehouse, along with Republican Representative Pat Harrigan, asked the Commerce Department to add BellTroX, CyberRoot, and Sunkissed Organic Farms Pvt. Ltd. (formerly known as "Appin Technology Pvt. Ltd.") and its subsidiaries, to the Commerce Department's Entity List. Such a designation would cut them off from U.S. software, cloud infrastructure, and cybersecurity tools.
Sunkissed representatives, CyberRoot and the Commerce Department did not respond to requests for comment. BellTroX could not be reached for comment.
All three companies have been described in media coverage and in reports published by major tech firms as being fronts for hack-for-hire activities.
In 2022, Reuters named CyberRoot and BellTroX as key players in the cybermercenary industry, saying they were frequently tapped by Western lawyers and private investigators to spy on one another during legal and business disputes. A 2023 Reuters report identified Appin as a pioneer in the field, saying the company grew from an educational startup to a hack-for-hire powerhouse that stole secrets from executives, politicians, military officials and wealthy elites around the globe.
#three
2 months ago
Minnesota Vikings OT Christian Darrisaw (non-injury) did not practice Friday, Sept. 11, but is not listed on the Week 1 injury report. S Harrison Smith (non-injury) was a limited participant and does not carry an injury designation. S Jakobe Thomas (illness), S Jacob Thomas (ankle) and OT Caleb Tiernan (ankle) fully participated and have been removed from the injury report.
SOURCE: Packers.com
This article originally appeared on USA TODAY: Week 1 injury report for Minnesota
#minnesota #week #thomas #darrisaw
SOURCE: Packers.com
This article originally appeared on USA TODAY: Week 1 injury report for Minnesota
#minnesota #week #thomas #darrisaw
2 months ago
Dallas Cowboys OT Ajani Cornelius (knee) and DT Jonathan Bullard (groin) fully participated in practice Friday, Sept. 11, and do not carry an injury designation for the Week 1 game against the New York Giants.
SOURCE: DallasCowboys.com
This article originally appeared on USA TODAY: Week 1 injury report for Cowboys
#ajani #bullard
SOURCE: DallasCowboys.com
This article originally appeared on USA TODAY: Week 1 injury report for Cowboys
#ajani #bullard
2 months ago
EAST RUTHERFORD - The Giants are listing star wide receiver Malik Nabers as questionable for Sunday's game against The Dallas Cowboys in the season opener for both teams.
Nabers was a full participant in practice Friday for the third consecutive day, but his status remains uncertain because of the game designation.
No other Giants player will carry an injury status into the game.
Giants coach John Harbaugh and Nabers have both indicated that this decision on when to return will be made at the player's discretion.
"The decision is the decision," Nabers said Thursday. "Everyone has to understand that, at the end of the day, it's my career. It's my body. I know when I'm able to play, and I know when I'm able to do what I want to do. So, everybody's got to live with the decision on what I want to do with my career."
#know
Nabers was a full participant in practice Friday for the third consecutive day, but his status remains uncertain because of the game designation.
No other Giants player will carry an injury status into the game.
Giants coach John Harbaugh and Nabers have both indicated that this decision on when to return will be made at the player's discretion.
"The decision is the decision," Nabers said Thursday. "Everyone has to understand that, at the end of the day, it's my career. It's my body. I know when I'm able to play, and I know when I'm able to do what I want to do. So, everybody's got to live with the decision on what I want to do with my career."
#know
2 months ago
The Detroit Lions will enter Week 1 with only one player carrying an injury designation for Sunday's opener against the New Orleans Saints.
Defensive back Christian Izien is questionable with a groin injury after being limited throughout the week. Everyone else listed on Detroit's final report finished Friday as a full participant and carries no game-status designation.
That includes rookie edge rusher Derrick Moore and defensive lineman Mekhi Wingo, who both progressed from limited participation Wednesday and Thursday to full participation Friday. Detroit's official final Week 1 injury report leaves Izien as the only legitimate availability question heading into the weekend.
That is a considerably cleaner injury picture than Detroit faced during much of training camp.
Moore's progression is particularly encouraging.
#injury #detroit #designation
Defensive back Christian Izien is questionable with a groin injury after being limited throughout the week. Everyone else listed on Detroit's final report finished Friday as a full participant and carries no game-status designation.
That includes rookie edge rusher Derrick Moore and defensive lineman Mekhi Wingo, who both progressed from limited participation Wednesday and Thursday to full participation Friday. Detroit's official final Week 1 injury report leaves Izien as the only legitimate availability question heading into the weekend.
That is a considerably cleaner injury picture than Detroit faced during much of training camp.
Moore's progression is particularly encouraging.
#injury #detroit #designation
2 months ago
49ers tight end George Kittle and pass rusher Nick Bosa had no injury designations, and they indeed will play the season opener.
The team announced its inactives ahead of Thursday night's season opener against the Rams in Melbourne.
Quarterback Kurtis Rourke, cornerback Ephesians Prysock, running back Jordan James, wide receiver Jordan Watkins, linebacker Tatum Bethune and offensive tackle Enrique Cruz are the 49ers' inactives. Rourke is the emergency third quarterback.
49ers defensive tackle James Thompson (hamstring) was the only player on either team with an injury designation aside from Rams defensive lineman Aaron Donald, who did not make the trip after recently coming out of retirement. Thompson is dressed for the game.
The 49ers placed defensive tackle Alfred Collins on season-ending injured reserve earlier. Collins tore a patellar tendon during practice earlier this week.
#season #tackle #jordan #quarterback
The team announced its inactives ahead of Thursday night's season opener against the Rams in Melbourne.
Quarterback Kurtis Rourke, cornerback Ephesians Prysock, running back Jordan James, wide receiver Jordan Watkins, linebacker Tatum Bethune and offensive tackle Enrique Cruz are the 49ers' inactives. Rourke is the emergency third quarterback.
49ers defensive tackle James Thompson (hamstring) was the only player on either team with an injury designation aside from Rams defensive lineman Aaron Donald, who did not make the trip after recently coming out of retirement. Thompson is dressed for the game.
The 49ers placed defensive tackle Alfred Collins on season-ending injured reserve earlier. Collins tore a patellar tendon during practice earlier this week.
#season #tackle #jordan #quarterback
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
2 months ago
Kansas City Chiefs have provided their first injury update ahead of their Week 1 meeting with the Denver Broncos, with Patrick Mahomes among eight players listed on the report.
Mahomes was listed with a knee issue but was able to participate fully in Thursday's practice. Several other notable Chiefs players also took part in the session without any restrictions.
Photo by Jamie Squire/Getty Images
Xavier Worthy was listed with a shoulder issue, while Rashee Rice appeared on the report with a knee problem. Guard Trey Smith was listed with a hip issue.
The defensive side of the team also featured several names, with Ashton Gillotte listed with a foot issue and R Mason Thomas carrying a hamstring designation. Jack Cochrane was listed with a knee issue, while L'Jarius Sneed was also included with a knee issue.
#listed #knee #kansas
Mahomes was listed with a knee issue but was able to participate fully in Thursday's practice. Several other notable Chiefs players also took part in the session without any restrictions.
Photo by Jamie Squire/Getty Images
Xavier Worthy was listed with a shoulder issue, while Rashee Rice appeared on the report with a knee problem. Guard Trey Smith was listed with a hip issue.
The defensive side of the team also featured several names, with Ashton Gillotte listed with a foot issue and R Mason Thomas carrying a hamstring designation. Jack Cochrane was listed with a knee issue, while L'Jarius Sneed was also included with a knee issue.
#listed #knee #kansas
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
2 months ago
Bears wide receiver Rome Odunze continued to deal with a calf injury at Thursday's practice.
The Bears listed Odunze as a limited participant for the second straight day. Odunze was injured during practice last week and was called day-to-day by head coach Ben Johnson earlier this week.
Safety Xavier Woods (groin) was added to the report as a limited participant. Left tackle Ozzy Trapilo (knee) was limited for the second straight day.
The status of all three players for Sunday's game against the Packers will be updated when injury designations are determined on Friday. The same is true for quarterback Tyson Bagent (back), who has not practiced at all this week.
#participant #straight
The Bears listed Odunze as a limited participant for the second straight day. Odunze was injured during practice last week and was called day-to-day by head coach Ben Johnson earlier this week.
Safety Xavier Woods (groin) was added to the report as a limited participant. Left tackle Ozzy Trapilo (knee) was limited for the second straight day.
The status of all three players for Sunday's game against the Packers will be updated when injury designations are determined on Friday. The same is true for quarterback Tyson Bagent (back), who has not practiced at all this week.
#participant #straight
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
2 months ago
On August 5, Protagonist Therapeutics (NASDAQ:PTGX) reported second-quarter 2026 results that flipped the company from red ink to a $162.8 million profit, or $2.29 per diluted share, compared with a $34.8 million loss a year earlier. The swing came as the company banked payments tied to two drugs moving from the lab bench to the pharmacy counter: ICOTYDE, an oral psoriasis treatment, and rusfertide, an injectable now awaiting an FDA decision. Cash and marketable securities climbed to $849.5 million. Here's what's fueling the optimism, and what could complicate it.
The quarter marked the first full three months of commercial sales for ICOTYDE, which won FDA approval on March 18 for moderate-to-severe plaque psoriasis in patients 12 and older weighing at least 40 kg. That approval triggered a $50 million milestone payment and made ICOTYDE, according to the company, the first and only FDA-approved targeted oral peptide for the condition. Protagonist can still collect up to $580 million more in milestones from partner Johnson & Johnson, plus royalties that average around 7.25 percent at $4 billion in annual sales.
Rusfertide carries even more weight. Its new drug application sits under Priority Review with a PDUFA goal date in August, backed by Breakthrough Therapy, Orphan Drug, and Fast Track designations for polycythemia vera. Partner Takeda already paid Protagonist $200 million on an opt-out election in April, with another $200 million and a $75 million approval milestone still due, on top of royalties that can reach 29 percent of sales above $1.5 billion. Behind both drugs, PN-881, an oral IL-17 antagonist, is heading into a Phase 2b psoriasis program in early 2027 after Phase 1 data showed drug levels beating their pharmacokinetic targets, and a Phase 1 study just began for PN-477sc, an injectable obesity peptide.
Look closer at that $213.5 million in license and collaboration revenue, and $192.4 million of it traces to the proportional recognition of Takeda's initial opt-out payment, not repeatable product sales. A year earlier, the same line item was just $5.5 million, so the growth reflects a single deal event more than an operating business scaling up. And that opt-out itself cuts both ways: Protagonist gave up its right to develop and commercialize rusfertide on its own, trading full ownership for royalties and milestones that depend on Takeda's execution rather than Protagonist's.
Spending is also set to climb. Management expects research and development costs to increase significantly in the second half of 2026 versus the first half, driven by the new PN-881 Phase 2b program, manufacturing investments, and added headcount. General and administrative costs are rising too, largely on stock-based compensation. And rusfertide's fate still hinges on an FDA decision that hasn't happened yet, priority review or not.
#protagonist
The quarter marked the first full three months of commercial sales for ICOTYDE, which won FDA approval on March 18 for moderate-to-severe plaque psoriasis in patients 12 and older weighing at least 40 kg. That approval triggered a $50 million milestone payment and made ICOTYDE, according to the company, the first and only FDA-approved targeted oral peptide for the condition. Protagonist can still collect up to $580 million more in milestones from partner Johnson & Johnson, plus royalties that average around 7.25 percent at $4 billion in annual sales.
Rusfertide carries even more weight. Its new drug application sits under Priority Review with a PDUFA goal date in August, backed by Breakthrough Therapy, Orphan Drug, and Fast Track designations for polycythemia vera. Partner Takeda already paid Protagonist $200 million on an opt-out election in April, with another $200 million and a $75 million approval milestone still due, on top of royalties that can reach 29 percent of sales above $1.5 billion. Behind both drugs, PN-881, an oral IL-17 antagonist, is heading into a Phase 2b psoriasis program in early 2027 after Phase 1 data showed drug levels beating their pharmacokinetic targets, and a Phase 1 study just began for PN-477sc, an injectable obesity peptide.
Look closer at that $213.5 million in license and collaboration revenue, and $192.4 million of it traces to the proportional recognition of Takeda's initial opt-out payment, not repeatable product sales. A year earlier, the same line item was just $5.5 million, so the growth reflects a single deal event more than an operating business scaling up. And that opt-out itself cuts both ways: Protagonist gave up its right to develop and commercialize rusfertide on its own, trading full ownership for royalties and milestones that depend on Takeda's execution rather than Protagonist's.
Spending is also set to climb. Management expects research and development costs to increase significantly in the second half of 2026 versus the first half, driven by the new PN-881 Phase 2b program, manufacturing investments, and added headcount. General and administrative costs are rising too, largely on stock-based compensation. And rusfertide's fate still hinges on an FDA decision that hasn't happened yet, priority review or not.
#protagonist
2 months ago
The Seattle Seahawks have a new injury concern just days before opening the 2026 season against the New England Patriots.
Starting safety Ty Okada did not participate in practice, according to Seattle's Week 1 injury report. No injury had previously been publicly identified for Okada, making his absence one of the more noteworthy developments on the Seahawks' first report ahead of Wednesday night's opener.
Twenty-four hours earlier, Mike Macdonald had been mum about giving any injury updates during a press conference, noting Sunday's official reporting would suffice.
The report did not list a game-status designation for Okada. The injury column shown on the initial report also did not specify what kept him out of practice.
Heavy will update this story as soon as Seahawks head coach Mike Macdonald addresses the media and provides any additional information on Okada's status.
#england
Starting safety Ty Okada did not participate in practice, according to Seattle's Week 1 injury report. No injury had previously been publicly identified for Okada, making his absence one of the more noteworthy developments on the Seahawks' first report ahead of Wednesday night's opener.
Twenty-four hours earlier, Mike Macdonald had been mum about giving any injury updates during a press conference, noting Sunday's official reporting would suffice.
The report did not list a game-status designation for Okada. The injury column shown on the initial report also did not specify what kept him out of practice.
Heavy will update this story as soon as Seahawks head coach Mike Macdonald addresses the media and provides any additional information on Okada's status.
#england
2 months ago
SEOUL, South Korea (AP) — A group of Chinese artists is boycotting a major art exhibition in South Korea over the organizers' plans to use the name "Taiwan Pavilion" for an exhibition of works by Taiwanese artists.
China considers self-governing Taiwan to be part of its territory and rejects the island's claim to sovereignty. Beijing generally refers to Taiwan as "China's Taiwan region."
China's Foreign Ministry on Thursday criticized the South Korean organizers of the biennial Gwangju Biennale, one of Asia's most prominent art exhibitions, saying the organizers have "stubbornly clung to the wrongful practice, allowing China's Taiwan region to participate under a designation that is completely incompatible with its status."
Spokesperson Guo Jiakun said China hopes the South Korean government will uphold its political commitment to the "one China" principle through concrete action.
The Chinese artists said the same day that they were withdrawing from the festival, which opens Saturday and runs through mid-November.
#korean
China considers self-governing Taiwan to be part of its territory and rejects the island's claim to sovereignty. Beijing generally refers to Taiwan as "China's Taiwan region."
China's Foreign Ministry on Thursday criticized the South Korean organizers of the biennial Gwangju Biennale, one of Asia's most prominent art exhibitions, saying the organizers have "stubbornly clung to the wrongful practice, allowing China's Taiwan region to participate under a designation that is completely incompatible with its status."
Spokesperson Guo Jiakun said China hopes the South Korean government will uphold its political commitment to the "one China" principle through concrete action.
The Chinese artists said the same day that they were withdrawing from the festival, which opens Saturday and runs through mid-November.
#korean
2 months ago
From well down the hall, Dennis Robertson saw me coming.
Whether he recognized me or not, I'll never be sure. But once I stopped and identified myself, he looked me up and down, then broke into a huge grin.
"So nowww the San Antonio Express-News wants to talk," Robertson said.
The truth was, the San Antonio Express-News always did. But if Kawhi Leonard's uncle and adviser was gloating in that Oracle Arena hallway in Oakland, California, seven years ago, it was because he'd earned his right to do so.
At that moment, his nephew was the best all-around basketball player in the world, a designation he'd just proven beyond any reasonable doubt. In Game 4 of the 2019 NBA Finals, Leonard scored 36 points to go with 12 rebounds and four steals, and his Toronto Raptors were heading back to Canada one victory away from their first championship.
#kawhi
Whether he recognized me or not, I'll never be sure. But once I stopped and identified myself, he looked me up and down, then broke into a huge grin.
"So nowww the San Antonio Express-News wants to talk," Robertson said.
The truth was, the San Antonio Express-News always did. But if Kawhi Leonard's uncle and adviser was gloating in that Oracle Arena hallway in Oakland, California, seven years ago, it was because he'd earned his right to do so.
At that moment, his nephew was the best all-around basketball player in the world, a designation he'd just proven beyond any reasonable doubt. In Game 4 of the 2019 NBA Finals, Leonard scored 36 points to go with 12 rebounds and four steals, and his Toronto Raptors were heading back to Canada one victory away from their first championship.
#kawhi
2 months ago
Denny Hamlin may have bigger hardware on his mind over the next 10 weeks, but NASCAR's top driver through the first 26 races of 2026 finally has a trophy to show for it.
Hamlin finished the regular season atop the NASCAR Cup Series standings, securing the No. 1 seed for the newly revived Chase and a 25-point advantage over Ryan Blaney entering Sunday's postseason opener at Darlington Raceway.
There was just one unusual detail.
With NASCAR returning to a 10-race Chase format this season, the sanctioning body moved away from the official "regular-season champion" designation and trophy that had accompanied the previous playoff system.
Hamlin still got one anyway.
#blaney
Hamlin finished the regular season atop the NASCAR Cup Series standings, securing the No. 1 seed for the newly revived Chase and a 25-point advantage over Ryan Blaney entering Sunday's postseason opener at Darlington Raceway.
There was just one unusual detail.
With NASCAR returning to a 10-race Chase format this season, the sanctioning body moved away from the official "regular-season champion" designation and trophy that had accompanied the previous playoff system.
Hamlin still got one anyway.
#blaney
2 months ago
Las Vegas Raiders coach Klint Kubiak revealed at a press conference on Wednesday it was an Achilles injury that led to Keyron Crawford being placed on season-ending injured reserve thus ending the edge rusher's rookie year before it even started.
Crawford suffered the injury during Las Vegas' final preseason game against the San Francisco 49ers on Aug. 27, ending a promising summer for the Raiders' third-round pick from this year's draft. The Auburn product had emerged as a developing pass-rush option for the team and was expected to contribute behind Maxx Crosby and Kwity Paye in 2026.
The season-ending designation represents a significant setback for both Crawford and the Raiders, who will enter the regular season without one of their top young players. Crawford's absence has Patrick Johnson in line to have a bigger role at edge rusher in Las Vegas next season.
Kubiak and his staff will now have to redistribute Crawford's defensive snaps while managing the rookie's long-term rehabilitation.
The Raiders will begin the regular season on Sept. 13 against the Miami Dolphins, with Crawford expected to spend the season recovering from the Achilles injury.
#season #vegas #ending #injury
Crawford suffered the injury during Las Vegas' final preseason game against the San Francisco 49ers on Aug. 27, ending a promising summer for the Raiders' third-round pick from this year's draft. The Auburn product had emerged as a developing pass-rush option for the team and was expected to contribute behind Maxx Crosby and Kwity Paye in 2026.
The season-ending designation represents a significant setback for both Crawford and the Raiders, who will enter the regular season without one of their top young players. Crawford's absence has Patrick Johnson in line to have a bigger role at edge rusher in Las Vegas next season.
Kubiak and his staff will now have to redistribute Crawford's defensive snaps while managing the rookie's long-term rehabilitation.
The Raiders will begin the regular season on Sept. 13 against the Miami Dolphins, with Crawford expected to spend the season recovering from the Achilles injury.
#season #vegas #ending #injury
2 months ago
The Philadelphia Eagles finalized their initial 53-man roster by making more than 30 transactions, then used the practice squad to retain several developmental prospects and experienced reserves.
Philadelphia placed cornerback Jakorian Bennett and tight end Grant Calcaterra on injured reserve with designations to return Aug. 30. Both players had to make the initial roster before being moved to preserve their eligibility to return during the regular season.
The Eagles released 10 vested veterans who were not required to pass through waivers: linebacker Chance Campbell, wide receivers Britain Covey, Danny Gray and Quez Watkins, outside linebacker Tarron Jackson, guard Michael Jordan, running back Dameon Pierce, tight end Stone Smartt and cornerbacks Ambry Thomas and Shaun Wade.
Philadelphia waived the following 26 players:
DT Uar Bernard
#tight #return #jakorian
Philadelphia placed cornerback Jakorian Bennett and tight end Grant Calcaterra on injured reserve with designations to return Aug. 30. Both players had to make the initial roster before being moved to preserve their eligibility to return during the regular season.
The Eagles released 10 vested veterans who were not required to pass through waivers: linebacker Chance Campbell, wide receivers Britain Covey, Danny Gray and Quez Watkins, outside linebacker Tarron Jackson, guard Michael Jordan, running back Dameon Pierce, tight end Stone Smartt and cornerbacks Ambry Thomas and Shaun Wade.
Philadelphia waived the following 26 players:
DT Uar Bernard
#tight #return #jakorian
2 months ago
The Baltimore Ravens completed a significant roster transformation over the past four days, reducing their offseason group to 53 players and constructing a practice squad before turning their attention toward the September 13 season opener against the Colts. Baltimore began preparing for the deadline on August 26 by placing center Danny Pinter on injured reserve. Pinter suffered a torn patellar tendon during a joint practice with Minnesota. The Ravens also waived linebacker Reid Williford with an injury settlement.
The largest wave of moves arrived August 30. Baltimore placed cornerback Bilhal Kone and running back Adam Randall on injured reserve with designations to return. Both players counted against the initial 53 before being moved, allowing them to return after missing at least four regular-season games.
The Ravens then released five vested veterans: wide receiver Chris Moore, cornerback Amani Oruwariye, offensive tackle David Sharpe, safety K'Von Wallace and running back Jonathan Ward. Unlike players with fewer than four accrued seasons, those veterans immediately became free agents.
Baltimore also waived 28 players:
LB Michael Barrett
#four #pinter #reserve
The largest wave of moves arrived August 30. Baltimore placed cornerback Bilhal Kone and running back Adam Randall on injured reserve with designations to return. Both players counted against the initial 53 before being moved, allowing them to return after missing at least four regular-season games.
The Ravens then released five vested veterans: wide receiver Chris Moore, cornerback Amani Oruwariye, offensive tackle David Sharpe, safety K'Von Wallace and running back Jonathan Ward. Unlike players with fewer than four accrued seasons, those veterans immediately became free agents.
Baltimore also waived 28 players:
LB Michael Barrett
#four #pinter #reserve
2 months ago
FOXBOROUGH, Mass. – Mike Vrabel had his eye on Corey Kiner ahead of the 2025 NFL Draft.
But the running back out of LSU ultimately went undrafted and ended up signing with the San Francisco 49ers' practice squad. His stint lasted until the middle of August that same year, when he was waived with an injury designation. The Minnesota Vikings signed him to the practice squad in September 2025, and then in December, he was signed to the Arizona Cardinals' active roster. That's where he remained until the end of this summer, when the New England Patriots traded for Kiner shortly before the roster cut deadline.
It was a call he didn't expect, but one he was happy to receive.
"I was a little shocked. I was happy, though," he told Patriots Wire in an one-on-one conversation on Tuesday. "Just very happy that I was getting the opportunity to come be on a 53-man roster."
Roster cutdown day is one of the hardest in the NFL, but some teams, especially those at the bottom of the waiver wire, will look to trade with another team to acquire a player they had their eye on, in an effort to ensure they get them. That's what the Patriots did with Kiner.
#wire #signed
But the running back out of LSU ultimately went undrafted and ended up signing with the San Francisco 49ers' practice squad. His stint lasted until the middle of August that same year, when he was waived with an injury designation. The Minnesota Vikings signed him to the practice squad in September 2025, and then in December, he was signed to the Arizona Cardinals' active roster. That's where he remained until the end of this summer, when the New England Patriots traded for Kiner shortly before the roster cut deadline.
It was a call he didn't expect, but one he was happy to receive.
"I was a little shocked. I was happy, though," he told Patriots Wire in an one-on-one conversation on Tuesday. "Just very happy that I was getting the opportunity to come be on a 53-man roster."
Roster cutdown day is one of the hardest in the NFL, but some teams, especially those at the bottom of the waiver wire, will look to trade with another team to acquire a player they had their eye on, in an effort to ensure they get them. That's what the Patriots did with Kiner.
#wire #signed
2 months ago
The NFL has concluded the preseason, and teams are now preparing for the regular season. Roster cutdowns, PUP List decisions and injured reserve designations have made each team's plans a little clearer as key players work toward the season opener.
Among those players, San Francisco 49ers star tight end George Kittle is making an unprecedented push to play in week one. After suffering a torn Achilles late last season, he is looking to make history with his recovery by being ready for the 49ers' trip to Australia.
On Wednesday, reports indicated that Kittle is on track to play. Most importantly, he is making the trip to Australia as the 49ers prepare to take on the Los Angeles Rams in Melbourne.
MORE: Cowboys will regret cutting Joe Milton before October
"The 49ers leave today for their game vs the Rams in Australia, and star TE George Kittle will make the trip after 2 positive days of practice, sources say. Kittle is trending in the right direction to play. DE Nick Bosa, ramping up with his knee, will also make the trip." Ian Rapoport reported on X.
#players
Among those players, San Francisco 49ers star tight end George Kittle is making an unprecedented push to play in week one. After suffering a torn Achilles late last season, he is looking to make history with his recovery by being ready for the 49ers' trip to Australia.
On Wednesday, reports indicated that Kittle is on track to play. Most importantly, he is making the trip to Australia as the 49ers prepare to take on the Los Angeles Rams in Melbourne.
MORE: Cowboys will regret cutting Joe Milton before October
"The 49ers leave today for their game vs the Rams in Australia, and star TE George Kittle will make the trip after 2 positive days of practice, sources say. Kittle is trending in the right direction to play. DE Nick Bosa, ramping up with his knee, will also make the trip." Ian Rapoport reported on X.
#players
2 months ago
The Green Bay Packers released 30 players at final cuts, not including those players waived with injury designations. Matt LaFleur's team was able to return 13 of the 30 on the practice squad, but that leaves over half of the ex-Packers looking for a new NFL team.
Not every player cut will find another NFL home. But many will before the start of the 2026 regular season. One was claimed off waivers on Monday, and a few more found homes on practice squads across the NFL on Tuesday.
Tracking where the ex-Packers sign around the NFL:
DL **** r Stackhouse: claimed off waivers by Tennessee **** ans
WR Will Sheppard: signed to Dolphins practice squad
#green
Not every player cut will find another NFL home. But many will before the start of the 2026 regular season. One was claimed off waivers on Monday, and a few more found homes on practice squads across the NFL on Tuesday.
Tracking where the ex-Packers sign around the NFL:
DL **** r Stackhouse: claimed off waivers by Tennessee **** ans
WR Will Sheppard: signed to Dolphins practice squad
#green
2 months ago
Howie Roseman did not close the door on a Zach Ertz reunion, but he also made it clear that the organization likes its current tight end group. Following the Eagles' 53-man roster cuts, Jimmy Kempski of Philly Voice asked Roseman whether the Eagles had spoken with Ertz or had interest in bringing the veteran back to Philadelphia.
"First, I'd say what an unbelievable player, what an unbelievable person, tremendous respect for him," Roseman said. "At the same time, love what we have going in our tight end room, too."
Ertz is nearing the nine-month point in his recovery from a significant knee injury. Nothing appears imminent, although Philadelphia has maintained contact with one of the most accomplished tight ends in franchise history.
"Have talked to Zach over a period of time, obviously rehabbing his ACL and the relationship, just like a lot of our former players who've been here," Roseman said.
The Eagles formed their initial roster with Dallas Goedert, Johnny Mundt, second-round pick Eli Stowers and E.J. Jenkins at tight end. Grant Calcaterra was placed on injured reserve with a designation to return, making him eligible to rejoin the roster after four games. That depth reduces the need to rush into an agreement with Ertz. It also gives Philadelphia time to monitor his recovery and evaluate its current group during the opening weeks.
#tight #roster #current #group
"First, I'd say what an unbelievable player, what an unbelievable person, tremendous respect for him," Roseman said. "At the same time, love what we have going in our tight end room, too."
Ertz is nearing the nine-month point in his recovery from a significant knee injury. Nothing appears imminent, although Philadelphia has maintained contact with one of the most accomplished tight ends in franchise history.
"Have talked to Zach over a period of time, obviously rehabbing his ACL and the relationship, just like a lot of our former players who've been here," Roseman said.
The Eagles formed their initial roster with Dallas Goedert, Johnny Mundt, second-round pick Eli Stowers and E.J. Jenkins at tight end. Grant Calcaterra was placed on injured reserve with a designation to return, making him eligible to rejoin the roster after four games. That depth reduces the need to rush into an agreement with Ertz. It also gives Philadelphia time to monitor his recovery and evaluate its current group during the opening weeks.
#tight #roster #current #group
2 months ago
The Atlanta Braves are making moves as September roster expansions approach. Atlanta has added right-handed relief pitcher Blake Burkhalter and veteran infielder Kyle Farmer to the active roster ahead of Tuesday's game against the Washington Nationals.
Burkhalter earns his long-awaited big-league debut after a stellar minor-league season. The 25-year-old has posted a 1.26 ERA with 46 strikeouts and a 1.12 WHIP across 35 2/3 innings in 26 appearances in relief this year.
MORE: Braves finally demote struggling hitter after Brewers series
Farmer is a nine-year big-league veteran who has already spent time with Atlanta earlier this season and brings bench depth. Across 15 games he has posted a .267 batting average, .250 on-base percentage and .583 OPS.
To clear a 40-man roster spot, the Braves transferred right-hander Robert Suarez to the 60-day injured list as he continues working back from right elbow inflammation. The move is procedural and keeps Suarez on the roster without requiring a waiver designation. His placement was backdated to when he first suffered the injury in June. When healthy this season, Suarez was outstanding, posting a 0.56 ERA with 26 strikeouts and four saves across 32 innings.
#right #burkhalter
Burkhalter earns his long-awaited big-league debut after a stellar minor-league season. The 25-year-old has posted a 1.26 ERA with 46 strikeouts and a 1.12 WHIP across 35 2/3 innings in 26 appearances in relief this year.
MORE: Braves finally demote struggling hitter after Brewers series
Farmer is a nine-year big-league veteran who has already spent time with Atlanta earlier this season and brings bench depth. Across 15 games he has posted a .267 batting average, .250 on-base percentage and .583 OPS.
To clear a 40-man roster spot, the Braves transferred right-hander Robert Suarez to the 60-day injured list as he continues working back from right elbow inflammation. The move is procedural and keeps Suarez on the roster without requiring a waiver designation. His placement was backdated to when he first suffered the injury in June. When healthy this season, Suarez was outstanding, posting a 0.56 ERA with 26 strikeouts and four saves across 32 innings.
#right #burkhalter
2 months ago
More former Texas A&M players are learning their fate as NFL teams finalize cuts to the 53‑man roster.
This stretch is always one of the most nerve‑wracking periods for players on the bubble, with situations changing hour to hour across the league. You can make the initial roster on cut day, only to be released the next day to make room for a waiver claim. It's a brutal cycle, and for many players, it doesn't truly sink in that they've made the team until Week 1 arrives.
Only then can they finally exhale.
Over the next few days, the bottom of NFL rosters will churn heavily, and there will be plenty to track as teams shuffle practice squads, injury designations, and late additions. As those moves roll in, follow along here at AggiesWire for every update involving former Texas A&M football players.
Contact/Follow us AggiesWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Texas A&M news, notes and opinions. Follow Jarrett Johnson on X: whosnextsports1.
#texas #former #roster
This stretch is always one of the most nerve‑wracking periods for players on the bubble, with situations changing hour to hour across the league. You can make the initial roster on cut day, only to be released the next day to make room for a waiver claim. It's a brutal cycle, and for many players, it doesn't truly sink in that they've made the team until Week 1 arrives.
Only then can they finally exhale.
Over the next few days, the bottom of NFL rosters will churn heavily, and there will be plenty to track as teams shuffle practice squads, injury designations, and late additions. As those moves roll in, follow along here at AggiesWire for every update involving former Texas A&M football players.
Contact/Follow us AggiesWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Texas A&M news, notes and opinions. Follow Jarrett Johnson on X: whosnextsports1.
#texas #former #roster
2 months ago
Well, that was a busy day.
Following 38 roster moves over the weekend, the Denver Broncos set their 17-player practice squad on Monday. Not everyone Denver would have liked to sign was available.
Two of the players the Broncos cut on Sunday — tight end Justin Joly (a fifth-round draft pick) and cornerback Reese Taylor — were claimed off waivers by the Miami Dolphins on Monday. Denver also lost defensive lineman Jordan Miller, who opted to join Miami's practice squad.
Also on Monday, Broncos outside linebacker Drew Sanders cleared waivers after being waived with an injury designation on Sunday and reverted to Denver's injured reserve list. View a recap of all of Monday's happenings (as of the time of publication) below.
RB Cody Schrader
#denver #Monday #sunday #justin
Following 38 roster moves over the weekend, the Denver Broncos set their 17-player practice squad on Monday. Not everyone Denver would have liked to sign was available.
Two of the players the Broncos cut on Sunday — tight end Justin Joly (a fifth-round draft pick) and cornerback Reese Taylor — were claimed off waivers by the Miami Dolphins on Monday. Denver also lost defensive lineman Jordan Miller, who opted to join Miami's practice squad.
Also on Monday, Broncos outside linebacker Drew Sanders cleared waivers after being waived with an injury designation on Sunday and reverted to Denver's injured reserve list. View a recap of all of Monday's happenings (as of the time of publication) below.
RB Cody Schrader
#denver #Monday #sunday #justin
